INTRODUCTION
During mammalian development, proliferation and cell death of tissue-specific progenitor and stem cells (SCs) need to be tightly monitored and controlled to produce organs of a predetermined size. Experimental manipulation of SC numbers or activity during embryogenesis can thus have striking effects on the final size of certain organs (Depaepe et al., 2005; Kim et al., 2005; Stanger et al., 2007) . Such exquisite regulatory mechanisms also orchestrate homeostasis of adult tissues and regenerative processes whereby the final shape and size of organs can be restored after cellular loss. Though a number of signaling molecules have been implicated in controlling SC proliferation, little is known about endogenous mechanisms that ''sense'' or provide information about organ size. It is also unclear how these mechanisms relay needs for tissue growth to its resident SCs and how these cues are translated into SC proliferation or apoptosis.
The Hippo signaling pathway was initially discovered in Drosophila as a potent mechanism that restricts tissue size by limiting cell proliferation and promoting apoptosis. At the core of this pathway is a kinase cascade composed of four tumor suppressors, including Hippo (Hpo) and Warts (Wts) and its regulatory proteins Salvador and Mats (Harvey et al., 2003; Lai et al., 2005; Pantalacci et al., 2003; Wu et al., 2003; Xu et al., 1995) . The Hpo-Sav complex phosphorylates and activates the Wts-Mats complex, which in turn phosphorylates and inactivates the transcriptional coactivator Yorkie (Yki) (Huang et al., 2005; Oh and Irvine, 2008) . Yki phosphorylation prevents its nuclear translocation (Dong et al., 2007; Oh and Irvine, 2008; Zhao et al., 2007) , wherein it acts as a coactivator for the TEAD/TEF family transcription factor Scalloped (Sd) (Wu et al., 2008; Zhang et al., 2008) . This core set of Hippo signaling components is highly conserved in mammals, and orthologs of Hpo (Mst1/2), Sav (WW45), Wts (Lats1/2), and Yki (Yap1) exhibit similar biochemical properties in cultured cells (Dong et al., 2007; Oka et al., 2008; Zhao et al., 2007) . The importance of Hippo signaling in mammalian organ size control has been studied extensively in the liver, where loss of Mst1/2 or Sav or overexpression of Yap1 lead to hepatomegaly (Camargo et al., 2007; Dong et al., 2007; Lu et al., 2010; Song et al., 2010; Zhou et al., 2009) . However, to what extent these predicted epistatic and functional relationships are conserved and active in other tissues remains uncertain (Zhou et al., 2009) .
Compared with the core kinase cascade regulating Yki phosphorylation, components acting upstream of this complex are less well defined. Earlier work in Drosophila has implicated the apical membrane-associated FERM-domain proteins Merlin (Mer), Expanded (Ex), and Kibra as pathway components upstream of Hpo (Baumgartner et al., 2010; Genevet et al., 2010; Hamaratoglu et al., 2006) . Recent studies further implicated the apical transmembrane protein Crumbs (Crb) (Robinson et al., 2010) and the atypical cadherin Fat (Ft) (Hariharan, 2006) as modulators of the fly Hippo pathway. However, with the exception of the mammalian Merlin ortholog NF2 , the significance and relevance of these proteins in regulating the activity of Yap1 in vivo in mammals are largely unclear. The identification of physiological upstream regulators of mammalian Hippo signaling could provide important insights into the mechanisms sensing and controlling organ size.
The mammalian epidermis is a rapidly regenerating epithelial tissue whose maintenance depends on the self-renewing ability of epidermal SCs residing in the basal layer. After division, shortlived progenitor cells leave the basal layer and move through the suprabasal layers to the tissue surface as they terminally differentiate (Fuchs, 2007) . Epidermal growth must be carefully balanced: inadequate proliferation results in thinning of the skin and loss of protection, and excessive growth is characteristic of hyperproliferative disorders. During development, the epidermis must be able to sense needs for expansion and replace basal vacancies, and during regeneration, cells must migrate and proliferate but also sense when to stop after wound closure. It has been postulated that adherens junctions (AJs), cadherin and catenin-based cell adhesion structures, might have a function in sensing epidermal cell density and restricting basal cell proliferation (Lien et al., 2006b ). For instance, loss of some, but not all, AJ components, such as a-catenin or p120-catenin, triggers severe epidermal hyperproliferation and tumors in transgenic mice (Kobielak and Fuchs, 2006; Perez-Moreno et al., 2006; Vasioukhin et al., 2001) . The mechanisms acting downstream of these complexes are not fully understood. Intriguingly, it has been recently found that NF2 can modulate epidermal development via an association with AJs, specifically a-catenin, and the Par3 polarity complex (Gladden et al., 2010) . These findings raise the possibility that signaling cues that regulate cell density and cell polarity could converge on the regulation of downstream Hippo signaling components.
Here, we utilize gain-and loss-of-function models in mice to show that Yap1 is an essential regulator of epidermal maintenance and SC proliferative capacity. In addition, we identify a-catenin, an AJ component and a known tumor suppressor in the skin, as a crucial upstream negative regulator of Yap1 in epidermal cells in vitro and in vivo. Our work identifies a direct link between a signaling component of cell density-dependent AJs and a transcriptional regulator and provides a paradigm for the regulation of tissue expansion in response to extracellular cues.
RESULTS

Activation of Yap1 Can Expand the Epidermal SC Compartment
In newborn mouse epidermis, Yap1 has a dynamic subcellular localization pattern in the basal compartment where it is present in the nucleus in some cells and in the cytoplasm/membrane of others. Expression of Yap1 is reduced and in a more diffuse nonnuclear pattern in the suprabasal-differentiated cell layers ( Figure 1A ). This pattern is also observed in cultured human keratinocytes in which high cellular densities lead to Yap1 relocalization out of the nucleus ( Figure 1B) . Thus, regulation of Yap1 subcellular localization might be important for the switch between proliferative and terminally differentiating compartments. To test this, we utilized transgenic mice carrying a doxycycline (Dox)-inducible allele of a mutated version of Yap1 (S127A). This mutation results in the enhanced nuclear localization of Yap1 (Camargo et al., 2007; Dong et al., 2007; Zhao et al., 2007) . To restrict Yap1 activation to the epidermis, we developed a binary genetic strategy based on the Cre-mediated activation of a reverse tetracycline-dependent transactivator selectively in the progeny of K14-expressing progenitors of stratified epithelia (Belteki et al., 2005; Dassule et al., 2000) ( Figure S1A available online). Mice carrying these transgenes will be referred to as Tg hereafter. Eight days after Dox administration, adult Tg mice developed thickening and wrinkling of the skin. Histological analyses demonstrated that, contrary to the typical one-/twocell layer common to adult mouse epidermis, Tg skin developed into a multilayered epithelium ( Figure 1C ). Staining for the proliferation marker Ki-67 revealed a substantial increase in the number of proliferating basal cells and an extension of the proliferative domain into the suprabasal layers, normally quiescent in control skin ( Figure 1D ). Tg epidermis contained an abundance of cells expressing progenitor markers such as K5 and K14, whereas expression of the differentiation markers K10 and loricrin was mostly abrogated ( Figure 1E and Figure S1B ). Additionally, the number of cells expressing p63, a SC marker and essential regulator of stemness in stratified epithelia (Senoo et al., 2007) , was amplified in Tg skin ( Figure 1F ). Tg skin failed to express hair follicle SC markers such as K15, or Sox9 (data not shown). These results suggested that activation of Yap1 induced expansion of an undifferentiated stem/progenitor cell population in the interfollicular epidermis. We then compared the clonogenic capacity of primary keratinocytes isolated 7 days after Dox administration. Skin of Tg mice had a >5-fold increase in the number of colony-forming cells compared to controls after Yap1 activation in vivo ( Figure 1E ). Moreover, serial plating assays, typically used to distinguish self-renewing SCs versus shorter-lived progenitors, revealed that Yap1 activation enhanced the SC proliferative capacity by 10-fold in secondary and tertiary platings ( Figure 1G and Figure S1C ). Taken together, these experiments demonstrate that activation of Yap1 promotes the proliferation of epidermal stem and progenitor cells and that its regulation is critical in maintaining normal skin homeostasis.
Activation of Yap1 Can Lead to Squamous Cell Carcinoma-like Tumors Tg mice became ill 8 days after Dox induction, likely because of similar dysplastic changes in mucosal tissues such as the tongue ( Figure S1D ). In order to assess the long-term effects of Yap1 activation, newborn Tg and control skin was grafted onto Nude-mouse recipients followed by Dox administration. Epidermal thickening, hyperkeratosis, and stunted hair growth were evident in Tg-grafted mice shortly after grafting. Beginning at 20 days, Tg grafts developed large tumor-like masses that subsequently ulcerated (Figure 2A ). Histological analyses revealed hyperplasia and multiple epidermal invaginations into the dermis as early as 9 days after grafting ( Figure 2B ). These lesions were epidermal in nature, as judged by staining with a pan-cytokeratin antibody and by their expression of keratin 6, which is expressed anomalously in hyperproliferative states (Figure 2C) . Donor origin of the tumors was confirmed by their expression of the Yap1 transgene ( Figure 2D and Figure S1E ). Overall, the morphological perturbations resembled those of squamous cell carcinoma (SCC) in situ in human ( Figure 2B ). By 42 days, full dermal invasion was evident, and this was associated with the rupture of the basement membrane ( Figure 2E ). At this stage, tumors resembled human sarcomatoid SCC, characterized by the presence of invasive atypical proliferating spindle cells intermingled with keratinized centers ( Figure 2B and Figures S1F and S1G). As predicted from their morphology, invading cells stained mostly negative for keratin markers but expressed the mesenchymal marker vimentin, indicating a potential epithelial-mesenchymal transition, a common occurrence in advanced human SCC ( Figure 2E ). Tumors were also assessed for their renewal by performing secondary transfers by subcutaneous injection into Nude mice. All transplantations gave rise to large masses of similar morphology as their primary counterparts ( Figure S1H) . Our results here demonstrate that proper regulation of Yap1 activity is essential for tumor suppression in the epidermis.
Loss of Yap1 Results in Failure of Skin Expansion
To test the role of endogenous Yap1 in epidermal biology, we generated a conditional floxed (fl) allele of Yap1 by gene targeting ( Figure S2A ). Deletion of loxP-flanked exons 1 and 2 of Yap1 after breeding to K14-Cre mice resulted in epidermis lacking Yap1 protein ( Figures S2B-S2D ). K14-Cre Yap1 (fl/fl) mice will be referred to as cKO mice hereafter. cKO mice were either aborted or died shortly after birth. Gross examination of mutant embryos at E18.5 revealed thinner and fragile skin and absence of epidermal tissue covering the distal part of the limbs (Figure 3A) . Assessment of skin permeability using the toluidine blue dye revealed a complete loss of epidermal barrier function in the regions described and around the mouth and nose (Figure 3B ). Histological analyses of the proximal limb skin of cKO mice revealed a thinner epidermis, reduced stratum corneum, and disorganized epidermal architecture ( Figure 3C ). Notably, the basal layer was hypoplastic, and basal cells had lost their columnar organization and adopted a flat morphology, typical of suprabasal differentiated cells ( Figure 3C ). These phenotypes were also observed in the back skin of cKO mice but were less severe. At E18.5, mutant cells expressing K10, an early differentiation marker, were nearly juxtaposed to the basement membrane in contrast to control skin where the basal layer was more pronounced ( Figure 3D ). Staining of cKO skin with progenitor markers demonstrated their abnormal morphology and reduction in numbers ( Figure 3E ). Staining with the proliferation marker phosphohistone H3 (pH3) revealed a >3.5-fold decrease in the number of proliferating basal cells in proximal limb skin of cKO mice ( Figure 3F and Figure S2E ). No discernible difference in apoptotic cells was detected, as judged by staining with active caspase 3 (data not shown). To directly address whether Yap1 deletion had an effect on the proliferative potential of epidermal SCs, we performed clonogenic assays. These experiments demonstrated a >50-fold decrease in the number of colonyforming cells and a decrease in colony size in cKO epidermis ( Figure 3G and Figure S2F ). This reduction in proliferative potential is likely the cause of the absence of skin in distal limb areas, where due to growth demands during development, the proliferation rate at E18.5 is more than 3-fold that of back skin (Figure S2E) . These results indicate that Yap1 is required for the maintenance of epidermal proliferative potential during development and, together with our gain-of-function experiments, suggest that levels of active Yap1 are a critical and physiological determinant of epidermal SC proliferative capacity.
TEAD Interaction Is Critical for the Role of Yap1 in the Epidermis
We next explored whether the ''canonical'' Hippo pathway components played a role in regulating Yap1 in the epidermis. In mammals, the transcription factors TEAD1-4 have been shown to interact with Yap1 and to mediate some of its proliferative effects in vitro (Vassilev et al., 2001; Zhao et al., 2008) . To test whether TEAD factors were also involved in the regulation of epidermal biology, we generated a reporter construct carrying multimerized copies of the consensus TEAD DNA binding sequence (TBS) to monitor their endogenous activity ( Figure 4A ). TBS reporter expression in a HaCaT keratinocyte cell line was highly responsive to Yap1, as its overexpression augmented reporter signal and its knockdown (KD) reduced reporter activity ( Figure 4A ). Proliferating cells in the periphery of colonies expressed the highest levels of the reporter, and reporter signal decreased when these cells were cultured at high densities, thus mimicking the observed pattern of Yap1 activity ( Figure 4B ).
Given the functional overlap among the four mammalian TEAD proteins, we decided to test their role in epidermal biology in vivo by genetically disrupting their interaction with Yap1. Through homologous recombination in ES cells, we mutated the Serine at position 79 of Yap1 to Alanine (S79A) (Figures S3A and  S3B ). The ortholog serine in human Yap1 (S94) is necessary to mediate a physical interaction with the TEAD proteins, but not with other DNA-binding cofactors (Zhao et al., 2008) . The predicted consequences of this mutation were tested in Yap1 fl/S79A mouse embryonic fibroblasts after administration of Cre, and we found that, whereas the overall levels of Yap1 protein were unchanged, its ability to interact with TEAD factors was mostly ablated ( Figure 4C ). We next generated K14-Cre Yap1 fl/S79A (S79A) mice, in which only the Yap1 mutant protein would be expressed in the epidermis of mice starting at E14.5. These mice died at birth and fully phenocopied cKO mice (Figure 4D ). S79A animals lacked epidermis in the distal part of the limbs, eyes, and ears. Mutant limb skin was thinner, with a reduced number of proliferating basal cells lying flat above the basal membrane ( Figure 4D and Figure S3C ). Clonogenic assays demonstrated a depletion of SC activity similar to cKO mice ( Figure 4E ). These results provide genetic evidence that TEADs are likely to be the major transcriptional partners of Yap1 in epidermal proliferation.
a-Catenin Interacts with Yap1 and 14-3-3
The mammalian orthologs of the Drosophila hippo kinase, Mst1 and Mst2, function upstream of Yap1 to mediate its phosphorylation and inactivation (Zhao et al., 2007) . Deletion of both Mst1 and Mst2 in the liver results in Yap1 activation and hepatomegaly, suggesting that these kinases can act as bona fide negative regulators in vivo (Song et al., 2010; Zhou et al., 2009) . We assessed whether deletion of Mst1/Mst2 in the skin would lead to similar phenotypes as Yap1 activation. Surprisingly, the epidermis of mice carrying a skin-specific deletion of Mst1/Mst2 displayed no abnormalities and no evidence of hyperplasia in mice up to 5 months of age (Figures S4A and S4B) . This was accompanied by no changes in Yap1 S127 phosphorylation in Mst1/Mst2 null keratinocytes ( Figure S4C ). Additionally, KD of Mst1/Mst2 in the HaCaT-TBS reporter line produced no change in reporter activity or Yap1 nuclear localization ( Figures S4D and S4E) . Similarly, knockdowns of Lats1 and Lats2, the orthologs of Drosophila warts, did not lead to increased reporter activity or enhanced Yap1 nuclear localization ( Figures S4D and S4E ). These results suggested that Yap1 might be regulated by alternative mechanisms in keratinocytes that are independent of the predicted canonical Hippo pathway kinases. In order to identify potential alternative upstream regulators of Yap1 activity, we performed coimmunoprecipitation (co-IP) experiments followed by mass spectrometry (MS) analysis in high-density HaCaT cultures. Unexpectedly, this screen revealed that the most common interaction partner of Yap1 in keratinocytes corresponded to a-catenin, an important tumor suppressor in stratified epithelia (Table S1 ). We next validated our mass spectrometry data by characterizing the interaction of Yap1 with a-catenin. Endogenous co-IP experiments in confluent HaCaT cells and keratinocytes directly isolated from skin, and pull-downs following transfection of tagged forms of Yap1 and a-catenin in 293T cells further demonstrate the biochemical interaction ( Figures 5A and 5B and Table S1 . Figure S5A ). Confocal microscopy studies in primary human keratinocytes corroborate these findings and reveal that Yap1 can begin to colocalize with a-catenin shortly after induction of differentiation following calcium treatment ( Figure 5C ). With more time in calcium or at high cell densities, nuclear Yap1 is depleted, with some of it colocalizing with a-catenin at the membrane and some accumulating in a cytoplasmic pool ( Figure S5B) .
Phosphorylation of Yap1 at Ser127 creates a 14-3-3 binding site that has been shown to be crucial for the regulation of its activity (Zhao et al., 2007) . Remarkably, disruption of 14-3-3-mediated regulation by mutation of Yap1 Ser127 to alanine nearly abolished the interaction between Yap1 and a-catenin ( Figures 5B and 5D ). The participation of 14-3-3 in Yap1 binding to a-catenin is further evidenced by the presence of a large number of 14-3-3 peptides found in our Yap1 mass spectrometry pull-downs (Table S1 ). We also find that the WW domains of Yap1, previously shown to be important for negative regulation by inhibitory kinases (Oka et al., 2008) , are also required for its efficient interaction with a-catenin ( Figure 5D ).
We next examined whether the interaction between a-catenin and Yap1 was direct using in vitro binding assays. Bacterially purified a-catenin and recombinant Yap1 purified from Sf9 cells were coincubated and subjected to pull-down assays. Our results reveal a lack of direct interaction between these two proteins ( Figures 5E and 5F ). Given that phosphorylation at Yap1 S127 and subsequent 14-3-3 binding are critical for the Yap1 and a-catenin association in cells, we tested whether 14-3-3 could allow for the formation of a tripartite complex in vitro. Indeed, the addition of bacterially purified 14-3-3 resulted in the association of Yap1 and a-catenin (Figures 5E and 5F). As predicted, this association was dependent on Yap1 phosphorylation, as pretreatment of phosphorylated recombinant Yap1 with lambda phosphatase resulted in loss of complex formation (Figures 5E and 5F ). Our results also provide evidence for a direct physical interaction between a-catenin and 14-3-3, which can be enhanced by the presence of phoshoYap1 ( Figure 5G ). Additionally, expression of a dominant-negative 14-3-3 mutant (K49E) in mammalian cells leads to a reduction of Yap1 and a-catenin binding ( Figure 5H ). Thus, these data uncover a-catenin as a binding partner for Yap1 and demonstrate that 14-3-3 is critical for this biochemical interaction.
a-Catenin Regulates Yap1 Localization and Activity
To test whether AJs are functionally important for the nonnuclear localization and inactivation of Yap1 at high cellular densities, keratinocyte cultures were treated with the calcium chelator EGTA. After only 1 min of EGTA treatment, the subcellular localization of Yap1 turned predominantly nuclear ( Figure 6A and Figure S5C) . The rapid kinetics of these observations indicates that AJs play a functional role in inactivating Yap1 and that the same pool of Yap1 can rapidly relocalize to the nucleus. To more specifically dissect the role of individual AJ proteins in regulating Yap1 activity, we depleted their expression in HaCaT and 293T cell lines carrying the TBS reporter. Remarkably, a robust activation of the reporter was observed after a-catenin KD, similar to levels obtained after depletion of the known upstream regulator NF2. A weaker but significant response was obtained after depletion of p120-catenin, and no reporter activation was observed after KD of b-catenin, E-cadherin, P-cadherin, or both E-and P-cadherins ( Figure 6B and Figures S5D and S5E) . a-catenin depletion activated the TBS reporter in several other cell lines tested, indicating a conserved phenomenon across epithelial cell types ( Figure S5F ). Silencing of a-catenin in confluent keratinocytes resulted in Yap1 relocalization to the nucleus and the formation of a Yap1/TEAD nuclear complex (Figure 6C-D) . a-catenin depletion was also accompanied by a reduction in the inhibitory phosphorylation at Yap1-S127 and minimal changes in the activation status of the Mst and Lats kinases ( Figure 6E ), suggesting that the regulatory effects of a-catenin might be independent of these kinases.
To extend these observations and to test whether a-catenin could be an important negative regulator of Yap1 in vivo, we examined Yap1 localization in a-catenin mutant tissues. We first analyzed Yap1 localization in epidermis of E18.5 mice with a K14-Cre driven deletion of a-catenin. Skin of control mice displayed the typical heterogeneous subcellular localization pattern in which only a few basal cells display predominant nuclear Yap1 protein ( Figure 6F ). This pattern was drastically changed in a-catenin mutant epidermis where basal cells were, in their great majority, positive for nuclear Yap1 and showed substantially enhanced nuclear staining ( Figure 6F and Figure S5G ). Additionally, in some regions, we observed nuclear Yap1 staining extending into the suprabasal cell compartment. Nuclear Yap1 was never seen suprabasally in control tissue ( Figure 6F ). We next evaluated the localization of Yap1 in a panel of 19 human skin SCCs that expressed varying levels of a-catenin ( Figure S5H ). As shown in Figure S5H , no or low expression of a-catenin clearly correlated with enhanced nuclear Yap1 localization in these tumors.
Having established that a-catenin is crucial for the inactivation of Yap1 in keratinocytes in vitro and in vivo, we tested whether ectopic expression of a-catenin could result in the recruitment of Yap1 to AJs. Remarkably, enforced expression of a-catenin in low-density cultures led to the relocalization of Yap1 to membrane regions containing AJ components ( Figure 6G and Figure S6A ). To test whether a different AJ protein could mediate this recruitment of Yap1 to the membrane, we performed similar experiments with E-cadherin. Cells that overexpressed E-cadherin, however, did not show localization of Yap1 to membrane regions ( Figure S6B ). These observations support the idea that a-catenin plays a direct role in the recruitment of Yap1 to AJs. This result, together with the siRNA depletion data ( Figure 6B ), speaks to the unique ability of a-catenin, and not E/P-cadherin or b-catenin, to regulate Yap1 localization and activity. These findings also argue that Yap1 hyperactivation is not due simply to loss of AJ-mediated cellular adhesion.
Genetic ablation of a-catenin in murine epidermis leads to keratinocyte hyperproliferation and squamous cell carcinoma (Kobielak and Fuchs, 2006; Vasioukhin et al., 2001) , observations that are highly reminiscent of the Yap1 gain-of-function phenotypes described here. Altogether, our data suggest that the growth-suppressive effects of a-catenin in the epidermis might be mediated through inactivation of Yap1. We tested this prediction experimentally and found that reduction of Yap1 levels in a a-catenin KD HaCaT cell line rescued its hyperproliferative phenotype to the level of control keratinocytes ( Figure 6H and Figures S6C-S6E) . Conversely, ectopic expression of a-catenin suppressed keratinocyte proliferation (Figure 6I ), but expression of Yap1-S127A was able to rescue these inhibitory effects ( Figure 6I ).
a-Catenin Binding Prevents Yap1 Dephosphorylation and Activation
Knockdown of a-catenin results in decreased Yap1 S127 phosphorylation, which is likely the cause of increased Yap1 nuclear localization and activity. To begin understanding the potential mechanisms linking a-catenin levels and Yap1 phosphorylation, we performed a Yap1 co-IP followed by MS in a-catenin KD cells. These experiments revealed a selective interaction of Yap1 with the catalytic subunit of the protein phosphatase 2A (PP2Ac) in cells with reduced a-catenin levels (data not shown). Co-IP and immunoblotting experiments confirmed this observation ( Figure 7A ). These results suggested that loss of a-catenin could result in a more efficient association of Yap1 and PP2Ac, which could potentially dephosphorylate Yap1-S127, triggering its activation. PP2A is a highly promiscuous enzyme that catalyzes the dephosphorylation of a wide range of substrates. Purified PP2Ac, in fact, is able to efficiently dephosphorylate Yap1 S127 in vitro in an okadaic acid-dependent manner (Figure 7B) . Importantly, reduction of PP2Ac levels in a-catenin KD cells suppresses the increase in TBS reporter activity and S127A phosphorylation observed after depletion of a-catenin ( Figure 7C and Figure S7 ). Thus, PP2Ac acts downstream or in parallel of a-catenin, and the increased Yap1 activity in a-catenin KD cells is dependent on PP2Ac activity.
An antagonistic and competitive interaction has been reported between PP2A and 14-3-3 for different phosphosubstrates (Chiang et al., 2003; Martin et al., 2008 ). Hence, we tested whether KD of a-catenin would result not only in increased association of Yap1 with PP2Ac, but also in reduced binding to 14-3-3. In effect, Yap1 does not seem to be bound to 14-3-3 in a-catenin KD keratinocytes ( Figure 7A ). To determine whether a Yap1, 14-3-3, and a-catenin complex could be protective against PP2Ac-mediated dephosphorylation, an in vitro dephosphorylation assay was performed in the presence and absence of these complex-forming proteins. Though the presence of 14-3-3 alone was not able to mitigate phosphatase activity, addition of a-catenin to the complex resulted in diminished dephosphorylation ( Figure 7D) .
One of the many PP2A complexes has been previously implicated in the regulation of Hippo signaling by controlling phosphorylation of the Hpo kinase in Drosophila (Ribeiro et al., 2010) . Our experiments in mammalian cells extend the role of PP2Ac as a regulator of mammalian Hippo signaling and suggest that a-catenin might regulate Yap1 activity by modulating its ability to be dephosphorylated at S127.
DISCUSSION
The present findings provide a mechanistic paradigm for the regulation of SC proliferation and tissue expansion in response to extracellular cues. In this molecular circuitry, cellular ''neighborhood'' information is provided by density-dependent cellcell junctions ( Figure 7E) . A critical and unique component of these junctions, a-catenin, acts as a signaling molecule to translate this context-dependent information into SC proliferation and tissue expansion. a-catenin achieves this through modulating the activity of Yap1, the transcriptional coactivator of the sizerestricting Hippo signaling pathway.
Yap1 as a Critical Regulator of Epidermal SCs
Relatively little is known about the transcriptional networks controlling epidermal SC maintenance. Arguably, only p63 and Tcf3/Tcf4 have been implicated as essential factors for the long-term proliferative capacity of epidermal SCs in vivo (Nguyen et al., 2009); Senoo et al., 2007) . Our work here provides loss-and gain-of-function genetic evidence indicating that Yap1 and the TEAD proteins are critical endogenous regulators of epidermal SC and progenitor proliferation. While this manuscript was under review, Zhang et al. reported that transgenic activation of Yap1 in the skin led to an expansion of basal epidermal progenitors and inhibition of terminal differentiation (Zhang et al., 2011) . These authors also find that nuclear Yap1 progressively declines with age and that it correlates with the proliferative potential of epidermal progenitors. Our work corroborates and extends these observations, and together they highlight the emerging role of Yap1 and TEAD factors in skin homeostasis. In the future, it will be important to identify the transcriptional targets of this complex that mediate its function.
Our results also extend previous observations linking Yap1/ TEAD activity to SC function. In the intestine, Yap1 activation leads to the expansion of an undifferentiated progenitor population (Camargo et al., 2007) , whereas its deletion causes no obvious defects during development or homeostasis, though it impairs regeneration . Loss of Yap1 in the liver leads to defective biliary development but unimpaired regeneration after partial hepatectomy F.D.C., unpublished data) . Thus, it seems that the requirement for endogenous Yap1 in tissue-specific SCs varies significantly according to the cellular context. The intrinsic need for Yap1/ TEAD activity in epidermal SCs during development is more akin to the role that this complex plays in human embryonic SCs, in which it is required for their self-renewal and suppression of differentiation (Lian et al., 2010) .
a-Catenin as a Regulator of Yap1 Activity Our findings provide additional insight into the role of a-catenin in growth and tumor suppression. Previously, a-catenin was considered to be a simple structural linker between the cadherin/catenin complex and the actin cytoskeleton. During the past several years, it has become evident that a-catenin also functions as a signaling molecule in a variety of cellular processes in addition to its role in cellular adhesion (Stepniak et al., 2009) . Interestingly, ablation of epidermal E-and P-cadherins leads to AJ disruption, defects in intracellular adhesion, and epidermal integrity but no significant increase in cellular proliferation (Tinkle et al., 2008) . These findings, together with our data ( Figure 6B and Figure S5D ), demonstrate that hyperproliferation and Yap1 activation in the absence of a-catenin are not simply due to loss of cell adhesion and epithelial integrity. Additionally, in human cancers, loss of a-catenin is usually a stronger prognostic factor than loss of Ecadherin (Benjamin and Nelson, 2008) . Thus, though it seems that AJ components function coordinately in mediating keratinocyte adhesion, they differ in their ability to influence proliferative responses. Particularly, it was shown that aberrant activation of the Ras-MAPK pathway was partially responsible for the hyperproliferative phenotypes observed in a-catenin mutant skin (Vasioukhin et al., 2001) . It is still unclear to what extent Yap1, Ras-MAPK, or other signaling pathways contribute to growth suppression mediated by a-catenin in the skin. Whether Yap1 mediates all or only part of a-catenin tumor-suppressive activity awaits the results of epistatic experiments in vivo.
14-3-3 and Yap1 Phosphorylation in the Skin Our data would suggest that 14-3-3 proteins are also critical growth suppressors in the epidermis. The 14-3-3 proteins are a large group of highly conserved and homologous dimeric proteins. A particular isoform, 14-3-3s, is unique among the family in that it is selectively expressed in stratified epithelia. Interestingly, 14-3-3s is barely detectable in basal cells but is abundantly expressed in the suprabasal layer of human epidermis (Dellambra et al., 2000) . Downregulation of 14-3-3s in primary keratinocytes results in the expansion and immortalization of cells expressing p63 (Dellambra et al., 2000; Pellegrini et al., 2001 ). Additionally, the epidermis of mice carrying a dominant-negative mutation in 14-3-3s displays hyperplasia, expansion of K14 and K5-expressing progenitor cells, and enhanced proliferative capacity in vitro (Herron et al., 2005; Li et al., 2005) . These phenotypes are reminiscent of Yap1 overexpression and a-catenin deletion in the epidermis and further indicate that 14-3-3s is part of a critical molecular circuitry controlling epidermal progenitor expansion.
As predicted from work in Drosophila, Mst1/2 and Lats1/2 are critical for Yap1 S127 phosphorylation in a wide array of cell lines (Dong et al., 2007; Oh and Irvine, 2008; Zhao et al., 2007) . Our data here demonstrate that Mst1/2, and potentially Lats1/2, are dispensable for Yap1 phosphorylation and activity in the epidermis. Our results parallel those of Zhao et al. and identify an unexpected diversity in the mammalian kinase components that are necessary to phosphorylate Yap1 in relation to what is predicted from work in Drosophila. For instance, in mouse liver, Mst1/2 signal through an unknown intermediary kinase that is distinct from Lats1/2 to control Yap1 phosphorylation. On the other hand, mouse embryonic fibroblasts do not require Mst1/ 2 but do depend on Lats1/2 to phosphorylate Yap1 (Zhao et al., 2007) . We have tested whether pharmacological manipulation of MAP kinase and insulin signaling, pathways that were previously shown to be involved in a-catenin signaling (Vasioukhin et al., 2001) , had effects on Yap1 phosphorylation. Inhibition of IGFR, JNK, and Src kinases resulted in no relative change in Yap1-S127 phosphorylation (data not shown). Thus, the identity of the kinases that are responsible for Yap1 inactivation in the epidermis remains unknown.
Several examples exist in the literature that demonstrate that competition between 14-3-3 proteins and PP2A complexes for a substrate is critical for regulation (Chiang et al., 2003; Martin et al., 2008) . Our data suggest that binding of the Yap1/14-3-3 complex to a-catenin would stabilize this complex and/or inhibit access of PP2Ac (Figure 7) . When binding to a-catenin is lost, PP2Ac could then more efficiently compete for binding to S127 in Yap1 and could dephosphorylate it, allowing Yap1 to translocate into the nucleus, bind to TEADs, and activate a proproliferative gene expression program (Figure 7) . Recently, a-catenin has been found to interact with NF2, another upstream component of the Hippo pathway (Gladden et al., 2010) . Interestingly, it was reported that NF2 could link a-catenin to Par3, thus providing a bridge between AJs and polarity complexes. Together with the recent identification of the apical polarity protein Crumbs as a functional regulator of the Hippo pathway Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010; Varelas et al., 2010) , these findings raise the intriguing possibility that a signaling complex of a-catenin, NF2, and other cell polarity proteins that are associated with the cell membrane could make up an important signaling hub that may allow cells to sense cues such as density and positioning. These complexes then could relay those signals to transcriptional effectors such as Yap1 (see below). The LIM protein Ajuba might provide an additional avenue for crosstalk between AJs and Hippo signaling. Ajuba can interact with a-catenin and has been recently shown to inhibit Yap1 phosphorylation via interaction with Lats (Das Thakur et al., 2010) . Further studies are needed to determine whether and to what extent a-catenin, NF2, and polarity complexes in epidermal cells control proliferation through Yap1.
Crowd Control and the Hippo Pathway
An important longstanding question in the Hippo signaling field is the identity of extracellular signals that modulate the pathway's activity. It has been speculated that this pathway could be involved in interpreting morphogen gradients to regulate tissue size, and therefore the existence of a secreted or membrane ligand has been postulated (Harvey and Tapon, 2007) . Our data here suggest that, in the epidermis, this regulation is, at least partly, mediated by a-catenin and AJs. Based on the massive overgrowth phenotypes obtained by deletion of a-catenin in the skin and the developing brain, Vasioukhin et al. postulated that AJs could act as molecular biosensors of cell density and positioning (Lien et al., 2006a (Lien et al., , 2006b . Our data here support and extend this notion and indicate that Yap1, through its interaction with a-catenin, is a critical mediator of this ''crowd control'' molecular circuitry in the epidermis (Figure 7 ). In this model, increased cellular density or differentiation (which is sensed by an increased number of AJs), higher calcium concentration (Menon and Elias, 1991) , and selective expression of 14-3-3 in the suprabasal layers limit SC expansion by inactivating Yap1. Low basal cell density, as in a growing embryo or after wounding, would translate into nuclear Yap1 and proliferation. When this molecular network is defective, e.g., by deletion of a-catenin, inactivation of 14-3-3, or activation of Yap1, hyperproliferation and tumors can arise. Further elucidation of the transcriptional program controlled by Yap1 and identification of modulators of its interaction with a-catenin, including the kinase that mediates Yap1 inactivation in keratinocytes, will likely provide insights into the mechanisms that underlie SC maintenance, tissue expansion, and tumorigenesis.
EXPERIMENTAL PROCEDURES
Generation of Gene-Targeted Mice For generation of cKO mice, a targeting strategy was designed to allow Cremediated deletion of exon 1 and 2 of Yap1. Progeny carrying the targeted Yap1 allele were bred to K14-Cre mice. To generate the mutated Yap1 S79A allele, a point mutation was introduced by site-directed PCR mutagenesis in the mYap1-targeting construct substituting a serine at amino acid position 79 (TCC) for an alanine (GCG). Mice were generated in the same way as described for the Yap1 fl/fl mice. Mice carrying the Yap1 S79A allele were bred to K14-Cre Yap1 fl/+ mice to generate K14 Cre Yap1 S79A/fl mice.
Cell Isolation, In Vitro Culture, and Clonogenic Assays Primary keratinocytes isolated from the epidermis of E18.5 control and transgenic mice were cultured on mitomycin-C-treated 3T3 feeder cells in FAD medium. For clonogenic assays, colonies of primary mouse keratinocytes were fixed and stained with 1% rhodamine B (Sigma) 9 days after initial plating.
Skin Engraftments and Barrier Function Assay
Full thickness skins of E18.5 K14-Cre Yap1 fl/fl and littermate Ctr mice were removed from torsos and spread on a sterile petri dish and briefly stored at 4 C. During this time, each skin graft recipient site was prepared by removal of a patch of full thickness skin on the back of an anesthetized Foxn1 nu / Foxn1 nu mouse. For skin barrier assays, newborn mice were rinsed in PBS and successively dehydrated in methanol for 1 min each. Mice were then rehydrated with PBS and stained in 0.1% toluidine blue in PBS, destained with PBS for 20 min, and then photographed.
Mass Spectrometry and Proteomic Analysis
Approximately 4 mg of precleared high-density HaCaT cells were used for Yap1 immunoprecipitation. Immunoprecipitates were loaded onto SDS-PAGE and stained with colloidal Coomassie. Mass spectrometry analysis was performed at the proteomics facility at Children's Hospital Boston.
Dephosphorylation Assay
Catalytically active recombinant PP2A (PP2Ac) was purchased from Millipore. Recombinant proteins were incubated in the presence of varying concentrations of PP2Ac. For PP2Ac and 14-3-3 competition assays, Yap1, a-catenin, and 14-3-3 were preincubated in 50 mM Tris (pH 7.4), 150 mM NaCl, 5 mM MgCl 2 , and 0.02% Triton X-100 for 1 hr prior to PP2Ac addition. 
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